132 related articles for article (PubMed ID: 11458875)
21. Abnormal occurrences for second quarter CY 1991; dissemination of information--Nuclear Regulatory Commission.
Fed Regist; 1991 Oct; 56(200):51919-21. PubMed ID: 10115357
[No Abstract] [Full Text] [Related]
22. Are we cutting the GRAS? Food safety perceptions are diminished by dysfunctional bureaucratic silos.
O'Reilly JT
Food Drug Law J; 2004; 59(3):417-26. PubMed ID: 15586991
[No Abstract] [Full Text] [Related]
23. Licensing a new industrial irradiator.
Bates NK; Entwistle FB
Health Phys; 2010 Feb; 98 Suppl 1():S12-6. PubMed ID: 20065665
[TBL] [Abstract][Full Text] [Related]
24. An inspector's perspective: teamwork between licensees and regulatory agencies.
Griffin JM
Health Phys; 2005 Aug; 89(2 Suppl):S22-6. PubMed ID: 16010115
[TBL] [Abstract][Full Text] [Related]
25. The U.S. NRC and the ADR process learning experiences.
Pérez-Monté JE
Health Phys; 2011 Nov; 101 Suppl 3():S160-3. PubMed ID: 21968823
[TBL] [Abstract][Full Text] [Related]
26. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
[TBL] [Abstract][Full Text] [Related]
27. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
[TBL] [Abstract][Full Text] [Related]
28. Licensing of low-power medical devices in the 450-470 MHz band--FCC. Final rule.
Fed Regist; 1992 Sep; 57(180):42706-7. PubMed ID: 10121197
[TBL] [Abstract][Full Text] [Related]
29. Abnormal occurrences for third quarter CY 1992; dissemination of information--NRC.
Fed Regist; 1993 Jan; 58(6):3571-3. PubMed ID: 10123373
[No Abstract] [Full Text] [Related]
30. Exempt distribution of a radioactive drug containing one microcurie of carbon-14 urea--NRC. Final rule.
Fed Regist; 1997 Dec; 62(231):63634-40. PubMed ID: 10176576
[TBL] [Abstract][Full Text] [Related]
31. Physical presence during gamma stereotactic radiosurgery.
Sheetz M; Swanson D; Yates B
Health Phys; 2009 Feb; 96(2 Suppl):S11-5. PubMed ID: 19125050
[TBL] [Abstract][Full Text] [Related]
32. EPA delays its new rule on radiation monitoring.
Luggiero G
Health Facil Manage; 1991 Jan; 4(1):32, 34, 36. PubMed ID: 10108680
[No Abstract] [Full Text] [Related]
33. Sex discrimination in prenatal radiation exposure policies of U.S. NRC licensees: U.S. NRC staff position.
Buchanan JD
Health Phys; 1990 Dec; 59(6):935. PubMed ID: 2228623
[No Abstract] [Full Text] [Related]
34. NRC simplifies regulations for medical use of byproduct material (10 CFR Part 35).
Frohman JE
J Nucl Med; 1987 Feb; 28(2):151-3. PubMed ID: 3806218
[No Abstract] [Full Text] [Related]
35. NRC workshop participants discuss the Part 35 petition and the QA rule.
Marcus CS
J Nucl Med; 1989 Oct; 30(10):1584-5. PubMed ID: 2795199
[No Abstract] [Full Text] [Related]
36. Nuclear safety: NRC investigates Seabrook.
Collins E
Nature; 1986 Nov 20-26; 324(6094):203. PubMed ID: 3785390
[No Abstract] [Full Text] [Related]
37. Government oversight of patient safety.
Alvarez R; Anderson M; Forst H; Kartha A; Pavlovic T; Serota S
J Healthc Qual; 2008; 30(6):57. PubMed ID: 19160876
[No Abstract] [Full Text] [Related]
38. Expanding the scope of practice for radiology managers: radiation safety duties.
Orders AB; Wright D
Radiol Manage; 2003; 25(4):40-7. PubMed ID: 12918277
[TBL] [Abstract][Full Text] [Related]
39. Society sues NRC over radiopharmacy rule.
Kotz D
J Nucl Med; 1995 Mar; 36(3):14N-15N, 20N-21N. PubMed ID: 7884491
[No Abstract] [Full Text] [Related]
40. Safety and compliance-related hazards in the medical practice: Part 2.
Calway RC
J Med Pract Manage; 2001; 17(1):28-31. PubMed ID: 11521535
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
